-
Loading metrics
Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia
- Petra Leidinger,
- Andreas Keller,
- Lisa Milchram,
- Christian Harz,
- Martin Hart,
- Angelika Werth,
- Hans-Peter Lenhof,
- Andreas Weinhäusel,
- Bastian Keck,
- Bernd Wullich
x
- Published: June 3, 2015
- https://doi.org/10.1371/journal.pone.0128235